Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-06-24 | New | $60,869,972 | $60,869,972 | Equity Only | 06b | SEC link |
2024-01-26 | New | $7,000,000 | $7,000,000 | Equity Only | 06b | SEC link |
2023-03-03 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
2021-11-15 | New | $220,000 | $220,000 | Equity Only | 06b | SEC link |
2021-11-15 | New | $26,000,000 | $26,000,000 | Equity Only | 06b | SEC link |
2020-06-03 | New | $8,500,000 | $8,500,000 | Equity Only | 06b | SEC link |
2019-01-30 | New | $11,000,000 | $11,000,000 | Equity Only | 06b | SEC link |
2018-06-29 | New | $4,282,548 | $4,282,548 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Xiaojia Cai | Director |
Cynthia Cai | Director |
Jianhua Cai | Director |
Jianfeng Fang | Director |
Li Hanxiong | Director |
Thomas Huang | Director |
John Leaman | Director |
Hanxiong Li | Director |
James Mackay | Director |
James Mc Kay | Director |
Zhang Mingyuan | Director |
Robert Orr | Director, Executive, Promoter |
Xiaodong Wang | Director |
Xin Xie | Director |
Xie Xin | Director |
Shunqi Yan | Director, Executive, Promoter |
Litain Yeh | Director, Executive, Promoter |
Chaohua Yuan | Director |
Yiwei Zhong | Director |
Yiwei Zong | Director |